Market Tracker

04/17 6:02pm ET

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

181.34
Delayed Data
As of Apr 17
 -2.94 / -1.60%
Today’s Change
147.30
Today|||52-Week Range
203.30
-1.99%
Year-to-Date

Today’s Trading

Previous close184.28
Today’s open182.00
Day’s range179.17 - 184.60
Volume1,063,661
Average volume (3 months)1,253,964
Market cap$36.2B
Dividend yield--
Data as of 3:59pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)+156.69%
Earnings growth (this year)+12.94%
Earnings growth (next 5 years)+21.19%
Revenue growth (last year)+46.49%
P/E ratio55.7
Price/Sales16.55
Price/Book10.93

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV+2.98+4.46%
VRTXVertex Pharmaceutica...-3.87-3.00%
PRGOPerrigo Company PLC-0.02-0.01%
SHPGShire+0.25+0.10%
Data as of 4:05pm ET, 04/17/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)$1.33
Annual revenue (last year)$2.2B
Annual profit (last year)$656.9M
Net profit margin29.66%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David L. Hallal
Chief Financial Officer &
Executive Vice President
Vikas Sinha
Corporate headquarters
Cheshire, Connecticut

Forecasts